Clinical experience sharing on common adverse reactions and relief methods of Pazopanib

Pazopanib is an oral multi-target tyrosine kinase inhibitor mainly used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. As an important drug for targeted therapy, pazopanib can effectively inhibit tumor angiogenesis and tumor cell proliferation, but during clinical use, patients often experience a series of adverse reactions. Understanding the common side effects of pazopanib and effective mitigation measures is crucial to improving patients' treatment compliance and quality of life. This article will comprehensively share the common adverse reactions of pazopanib and their treatment methods based on clinical experience.

1. Common adverse reactions of pazopanib

Common adverse reactions during treatment with pazopanib include fatigue, hypertension, abnormal liver function, diarrhea, stomatitis, rash, and hand-foot syndrome. Fatigue is the most common side effect. Patients often feel weak and lack of energy, which seriously affects their daily life. Hypertension is one of the typical toxic reactions of pazopanib, and patients need to monitor their blood pressure closely to prevent the occurrence of cardiovascular events. Abnormal liver function is manifested by elevated transaminases, which may lead to severe liver damage if not treated in time. Gastrointestinal symptoms such as diarrhea and stomatitis are also common, affecting patients' nutritional intake and quality of life. Skin-wise, hand-foot syndrome manifests as redness, swelling, pain, and peeling of the palms and soles of the hands and feet. In severe cases, hand-foot syndrome may cause inability to move.

2. Methods to alleviate adverse reactions

There are a variety of clinical mitigation measures for the side effects of pazopanib. For fatigue, it is recommended that patients take a moderate rest, maintain good sleep, do moderate light exercise to enhance physical strength, and supplement nutrition through a reasonable diet. Patients with hypertension should monitor their blood pressure regularly, use antihypertensive drugs if necessary, and avoid high-salt diet and emotional excitement. For abnormal liver function, doctors will recommend regular testing of liver function indicators. If abnormalities are found, it may be necessary to temporarily stop the medication or adjust the dose, and use liver-protective drugs in conjunction. Patients with diarrhea should pay attention to replenishing water and electrolytes, avoid irritating foods, and use antidiarrheal drugs in severe cases. If you have stomatitis, you need to keep your mouth clean, avoid spicy and rough foods, and use oral care solutions containing anti-inflammatory ingredients when necessary. For hand-foot syndrome, patients should keep the skin of their hands and feet moist, avoid friction and hot water immersion, and use topical moisturizers or analgesics when necessary.

3. Clinical experience sharing

In clinical practice, timely recognition and treatment of adverse reactions of pazopanib have an important impact on patient treatment compliance and efficacy. Doctors should inform patients in detail about possible side effects before treatment and guide patients in self-monitoring and care, especially monitoring of hypertension and abnormal liver function. Regular follow-up and laboratory examinations are key to ensuring medication safety. At the same time, multidisciplinary teamwork, such as oncology, internal medicine, nursing and nutrition departments, can provide patients with personalized management plans and significantly reduce adverse reactions.

Patient education is equally important, and patients are encouraged to promptly report symptoms of discomfort and avoid discontinuing medication on their own or adjusting doses at will. For serious side effects, safety can be ensured by reducing the dose of the drug, temporarily stopping the drug, or changing the treatment plan when necessary. By optimizing side effect management, not only can patients' quality of life be improved, but more patients can complete the course of treatment and achieve the best treatment effect.

Pazopanib, as an effective targeted anti-tumor drug, plays an important role in the treatment of renal cell carcinoma and soft tissue sarcoma. However, its side effects cannot be ignored. Common fatigue, hypertension, liver function abnormalities, gastrointestinal symptoms and hand-foot syndrome all require attention and timely intervention. Through scientific monitoring and multi-dimensional nursing measures, combined with the summary of clinical experience, these adverse reactions can be effectively alleviated and the safe medication and treatment effects of patients can be ensured. In the future, with further research on the toxic mechanism of pazopanib and improvement of management strategies, patients' medication experience and treatment prognosis are expected to continue to improve.

References：https://www.votrient.com/